Bone marrow hypocellularity and normal karyotype are the best prognostic factors in myelodysplastic syndromes (MDS)

被引:0
|
作者
Pecorari, P [1 ]
Orlandini, D [1 ]
Sceusa, R [1 ]
机构
[1] DEPT INTERNAL MED 4,I-34100 TRIESTE,ITALY
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:872 / 872
页数:1
相关论文
共 50 条
  • [1] Prognostic impact of bone marrow fibrosis in myelodysplastic syndromes (MDS)
    Baghikar, S.
    Braunstein, S.
    Reinecke, P.
    Knipp, S.
    Haas, R.
    Hildebrandt, B.
    Gattermann, N.
    Germing, U.
    Schmidt-Graef, A.
    [J]. LEUKEMIA RESEARCH, 2007, 31 : S100 - S100
  • [2] PROGNOSTIC FACTORS IN MYELODYSPLASTIC SYNDROMES (MDS)
    TRICOT, G
    VLIETINCK, R
    HENDRICKX, B
    VERWILGHEN, RL
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1985, 60 (02) : 362 - 362
  • [3] BONE-MARROW KARYOTYPE AND PROGNOSIS IN PRIMARY MYELODYSPLASTIC SYNDROMES
    BILLSTROM, R
    THIEDE, T
    HANSEN, S
    HEIM, S
    KRISTOFFERSSON, U
    MANDAHL, N
    MITELMAN, F
    [J]. EUROPEAN JOURNAL OF HAEMATOLOGY, 1988, 41 (04) : 341 - 346
  • [4] Mutation landscape of normal karyotype myelodysplastic syndromes and their prognostic impact
    Wang, Wei
    Zhang, Yudi
    Yang, Wenli
    Han, Yueyuan
    Jiang, Lingxu
    Liu, Xiaozhen
    Lang, Wei
    Luo, Yingwan
    Zhu, Shuanghong
    Zhou, Xinping
    Wang, Lu
    Ye, Li
    Ma, Liya
    Tong, Hongyan
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2024, 99 (02) : E51 - E54
  • [5] The Molecular Prognostic Scoring System for Normal Karyotype Myelodysplastic Syndromes
    Wang, Wei
    Zhang, Yudi
    Yang, Wenli
    Han, Yueyuan
    Ge, Zheng
    Tong, Hongyan
    [J]. BLOOD, 2023, 142
  • [6] Bone marrow transplantation (BMT) in children with myelodysplastic syndromes (MDS).
    Hoogerbrugge, PM
    Rossum, M
    Vries, E
    Gerritsen, EJA
    Weel, M
    Veer, ET
    Vossen, JMJJ
    [J]. BLOOD, 1995, 86 (10) : 353 - 353
  • [7] The myelodysplastic syndromes (MDS): Is bone marrow examination always necessary?
    Carmi, G.
    Oster, H. S.
    Kolomansky, A.
    Kyrzner, I.
    Naparstek, E.
    Comaneshter, D.
    Mittelman, M.
    [J]. LEUKEMIA RESEARCH, 2009, 33 : S117 - S117
  • [8] Involvement of bone marrow stroma in pathogenesis of myelodysplastic syndromes (MDS).
    Alvi, S
    Henderson, B
    Flores-Figueroa, E
    Zorat, F
    Shaher, A
    Mansoob, F
    Broderick, E
    Patel, S
    Khan, I
    Borok, RZ
    Raza, A
    [J]. BLOOD, 1999, 94 (10) : 161B - 161B
  • [9] Allogeneic bone marrow transplantation (alloBMT) in myelodysplastic syndromes (MDS).
    Karanes, C
    Abella, E
    Du, W
    Klein, J
    Dansey, R
    Cassells, L
    Peters, W
    Baynes, R
    [J]. BLOOD, 1998, 92 (10) : 659A - 659A
  • [10] ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR MYELODYSPLASTIC SYNDROMES (MDS)
    ARNOLD, R
    HEIMPEL, H
    [J]. BONE MARROW TRANSPLANTATION, 1989, 4 : 101 - 103